Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Weerawat Manosuthi, MD
Woman and Man Max 99 years
Weerawat Manosuthi, MD
Update Il y a 4 ans
Appropriate Timing of HAART in Co-infected HIV/TB Patients
To study the optimal timing to initiate antiretroviral therapy in HIV-infected patients who are receiving tuberculosis treatment between at 4 weeks and at 12 weeks after tuberculosis treat...
Country
Thailand
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Weerawat Manosuthi, MD
Update Il y a 4 ans
Efavirenz-based Versus Nevirapine-based Antiretroviral Therapy Among HIV-infected Patients Receiving Rifampin
The randomized controlled trial is conducted among antiretroviral naive co-infected HIV and tuberculosis patients who receiving rifampicin-based antituberculous regimen fro at least 4 week...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Weerawat Manosuthi, MD
Update Il y a 4 ans
Nevirapine Levels and Fluconazole
Nevirapine (NVP)-based antiretroviral therapy (ART) has been commonly used in many developing countries due to its affordability and feasibility. Nonetheless, the potential drug-drug inter...
Country
None
organs
None
Specialty
None
Closed trial
More information